The molecular mechanisms of alpha v beta 3 integrin affinity regulatio
n have important biological implications in tumour development, wound
repair and angiogenesis. We expressed, purified and characterized reco
mbinant forms of human alpha v beta 3 (r-alpha v beta 3) and compared
the activation state of these with alpha v beta 3 in its cellular envi
ronment. The ligand specificity and selectivity of recombinant full-le
ngth and double transmembrane truncations of r-alpha v beta 3 cloned i
n BacPAK6 vectors and expressed in Sf9 and High Five insect cells were
compared with those of native placental alpha v beta 3 and the recept
or in situ on the cell surface. r-alpha v beta 3 integrins were purifi
ed by affinity chromatography from detergent extracts of cells (full-l
ength), and from the culture medium of cells expressing double-truncat
ed r-alpha v beta 3. r-alpha v beta 3 had the same epitopes, ligand-bi
nding specificities, bivalent cation requirements and susceptibility t
o RGD-containing peptides as native alpha v beta 3. On M21-L4 melanoma
cells, alpha v beta 3 mediated binding to vitronectin, but not to vit
ronectin unless activated with Mn2+. Non-activated alpha IIb beta 3 in
tegrin as control in M21-L-IIb cells had the opposite profile, mediati
ng binding to fibrinogen, but not to vitronectin unless activated with
Mn2+. Thus these receptors had moderate to low ligand affinity. In ma
rked contrast, purified alpha v beta 3 receptors, with or without tran
smembrane and cytoplasmic domains, were constitutively of high affinit
y and able to bind strongly to vitronectin, fibronectin and fibrinogen
under physiological conditions. Our data suggest that, in contrast wi
th the positive regulation of alpha IIb beta 3 in situ, intracellular
controls lower the affinity of alpha v beta 3, and the cytoplasmic dom
ains may act as a target for negative regulators of alpha v beta 3 act
ivity.